Jump Financial, LLC Provention Bio, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $303,174 - $708,972	67,074 New	67,074 $708,000
Q2 2022 Aug 09, 2022	BUY	$3.65 - $7.3 $202,432 - $404,865	55,461 New	55,461 $222,000
Q4 2021 Feb 10, 2022	SELL	$5.59 - $7.39 $126,334 - $167,014	-22,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $127,916 - $188,258	22,600 New	22,600 $145,000
Q2 2021 Aug 13, 2021	SELL	$6.71 - $11.04 $113,399 - $186,576	-16,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $171,028 - $328,705	16,900 New	16,900 $177,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.